Wilson Disease Drugs Market Players:
- Merck & Co., Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bausch Health Companies Inc.
- Alexion Pharmaceuticals, Inc.
- Nobelpharma Co., Ltd.
- Kodmon Holdings, Inc.
- Teva Pharmaceutical Industries Ltd.
- Tsumura & Co.
- VHB Medi Sciences Limited
- Pfizer Inc.
- Lupin Limited
- Vivet Therapeutics
- NAVINTA LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of wilson disease drugs is evaluated at USD 724.71 million.
The global wilson disease drugs market size surpassed USD 697.71 million in 2025 and is projected to witness a CAGR of over 4.3%, crossing USD 1.06 billion revenue by 2035.
By 2035, North America is set to capture about 30% share of the wilson disease drugs market, stemming from the presence of leading market players in the region which manufacture and distribute Wilson disease drugs.
Key players in the market include Merck & Co., Inc., Bausch Health Companies Inc., Alexion Pharmaceuticals, Inc., Nobelpharma Co., Ltd., Kodmon Holdings, Inc., Teva Pharmaceutical Industries Ltd., Tsumura & Co., VHB Medi Sciences Limited, Pfizer Inc., Lupin Limited, Vivet Therapeutics, NAVINTA LLC.
